DDR on DTC: Lexiva

Share this article:
Having been born in 1997, DTC advertising is now officially a “teenager.” And just like any teen, it has its moments of rebellion (getting ready or a standoff with the FDA) as well as unexpected (but welcome) moments of insight and maturity.

One case in point is the latest campaign for Lexiva, an HIV drug from GlaxoSmithKline and its biotech partner, Vertex. While the print ad is typically straightforward and loaded with the usual caveats and disclaimers, the use of one emotionally connective word elevates its message and gives it tremendous power in encouraging patients to seek treatment. That word is “cherished.”

The headline, “I am cherished,” which runs above a photograph of a healthy, happy couple, hits the bull's-eye by downplaying “having a disease” in favor of “living a life.” The Lexiva website offers additional, powerful statements (“I am needed.” “I am loved.” “I am involved.”) combined with other equally impactful photos.

This is a riveting example of how a DTC ad can educate and persuade a patient to seek treatment. The campaign follows last year's Lexiva ad, which presented an HIV patient being overwhelmed with life's activities and “needing a treatment plan.” But that campaign could have been for any number of drugs or conditions. There is no mistaking the intent of the new ad. And there is no mistaking its effectiveness to break through to its target audience.

Kudos to GSK-Vertex for this beautifully simple, yet powerful ad!

Deborah Dick-Rath is SVP, healthcare practice leader, at FactorTG. Contact: deborah.dick-rath@factortg.com
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.